Elisabetta Munzone/X
Mar 22, 2025, 06:46
Elisabetta Munzone: CTCs enumeration as an early treatment monitoring tool in metastatic breast cancer
Elisabetta Munzone, Medical oncologist and Breast Cancer specialist at the European Institute of Oncology shared on X about recent paper by Wolfgang Janni et al., titled “Clinical validity of repeated circulating tumor cell enumeration as an early treatment monitoring tool for metastatic breast cancer in the PREDICT global pooled analysis” published on AACR Journals.
Authors: Wolfgang Janni et al.
“PREDICT Global Analysis confirms the clinical validity of repeated CTCs enumeration as an early treatment monitoring tool in metastatic breast cancer.
Among 4,436 patients, follow-up CTC status was strongly prognostic for OS, independent of tumor subtype and treatment.
CTC responders (positive to negative) had significantly better OS than non-responders (positive to positive) (HR 0.48, 95% CI 0.44–0.53).”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 1, 2025, 19:24
Aug 1, 2025, 19:14
Aug 1, 2025, 18:32